-

Open Letter to ViewRay Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies

WASHINGTON--(BUSINESS WIRE)--TeamBest Global Companies (TBG) have been in business since 1951—over 70 years—with many innovations in Brachytherapy, Teletherapy, IMRT treatment planning software, Heavy Ion 400 MeV ion, Rapid Cycling Medical Synchrotron Proton-to-Carbon, a range of cyclotrons from 1 MeV to 200 MeV for research, Radioisotope Production, Proton Therapy, Theranostics/Targeted Systemic Radiation Therapy, Blood, Animal Cell and Research Irradiators, etc.

I am saddened by ViewRay’s recent announcement that their operations will soon cease and that after October, their customers may not be able to receive support for service, maintenance, quality and regulatory issues, upgrades, etc.

TBG Companies have 1000s of Teletherapy units—Cobalt 60 Gamma Beam with IMRT capabilities on some, and 1000 plus X Ray, Cesium 137 Blood, Animal, Cell and Research Irradiators, among other products.

Yesterday, I issued a press release about TBG Companies’ interest in helping and finding a way to preserve ViewRay technology/products/software, etc. by recruiting Service Engineers, Software Engineers and seeking to have ViewRay or US FDA transfer the 510K to Best Medical International (BMI). Over 10 years ago, BeBig, a German company, acquired the 510K from US FDA for their Brachytherapy Seeds within days after their USA distributor filed for bankruptcy.

I have received positive responses from customers of ViewRay about our effort to save this valuable technology. In a similar situation in 2006, BMI acquired Novoste and their BetaCath Vascular Brachytherapy products. BMI/Novoste continues to serve nearly 75 or more customers while continuing to acquire new ones, since then.

Please feel free to reach out to me at krish@teambest.com to find a solution for this predicament. Best wishes.

For more information, please visit www.teambest.com or find out more about our new initiatives.

Contacts

Krishnan Suthanthiran, 703-451-2378, krish@teambest.com

TeamBest Global Companies


Release Summary
Krishnan Suthanthiran offers a solution for continued support and service to ViewRay customers.
Release Versions

Contacts

Krishnan Suthanthiran, 703-451-2378, krish@teambest.com

More News From TeamBest Global Companies

To Leaders of Canadian First Nations and Federal/Provincial Governments—Fueling the Future with Kitsault Energy

WASHINGTON--(BUSINESS WIRE)--In 2013, Dr. Suthanthiran, President/Founder of TeamBest Global Companies, announced his dedicated energy pipeline corridor/export port/terminal to carry all of Canada’s energy products to Kitsault, BC, Canada, a town owned by Suthanthiran, northwest of Prince Rupert, BC. Suthanthiran, a healthcare professional, has devoted over fifty years to cheering, helping, and saving lives daily. The dedicated pipeline corridor is now a reality, w/multiple pipelines approved a...

Best Vascular/Novoste Celebrates 24th Anniversary of Vascular Brachytherapy Approval & Use of by US FDA

WASHINGTON--(BUSINESS WIRE)--It’s been over 30 years since the first vascular brachytherapy (VBT) animal experiments and human clinical trials were performed and 24 years since the approval of VBT for human clinical use for the treatment of in-stent coronary artery restenosis by the US FDA on November 3, 2000. Dr. Paul Teirstein, at Scripps Clinic in La Jolla, California, in collaboration with Virginia-based Best Medical International (BMI), began the first randomized, double-blind human clinic...

BCF, BREF and TBG Companies Seek Global Financial Support to Establish 1000s of Best Cure Pro Health and Medical Centers

WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran is the Founder and President of the Best Cure Foundation (BCF), a non-profit 501(c)(3) corporation established in Springfield, Virginia, USA, in 2007. He also established the Brachytherapy Research & Education Foundation (BREF) as a non-profit in Springfield, Virginia, USA, in 1987. Additionally, Suthanthiran founded TeamBest Global (TBG) Companies in 1977 and has acquired several companies over the last 20 years. Suthanthiran's journey...
Back to Newsroom